Trgovina Genprex, Inc. - GNPX CFD
Dodaj med priljubljene- Povzetek
- Zgodovinski podatki
- Dogodki
- Izkaz poslovnega izida
- Bilanca stanja
- Denarni tok
- Lastništvo
Razmik | 0.0495 | ||||||||
Nočna pristojbina za nakup
Long position overnight fee
Pojdi na platformo | -0.024068% | ||||||||
Nočna pristojbina za prodajo
Short position overnight fee
Pojdi na platformo | 0.001846% | ||||||||
Čas nočne pristojbine | 21:00 (UTC) | ||||||||
Min. tržena količina | 1 | ||||||||
Valuta | USD | ||||||||
Kritje | 20% | ||||||||
Borza | United States of America | ||||||||
Provizija na trgovanje | 0% |
*Information provided by Capital.com
Predhodno. Zapri* | 0.8951 |
Odpri* | 0.8979 |
Enoletna sprememba* | -60.96% |
Dnevni razpon* | 0.8979 - 0.9201 |
Razpon 52 wk | 0.74-2.67 |
Povprečni obseg (10 dni) | 275.75K |
Povprečni obseg (3 meseci) | 8.57M |
Tržna kapitalizacija | 48.79M |
Razmerje P/E | -100.00K |
Število delnic v obtoku | 51.97M |
Prihodki | N/A |
EPS | -0.47 |
Dividenda (donosnost v %) | N/A |
Beta | -0.36 |
Datum naslednjega zaslužka | N/A |
Vse podatke je zagotovil Refinitiv, razen podatkov, označenih z zvezdico, ki so *podatki, ki jih je zagotovil Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Zapiranje | Change | Change (%) | Odpiranje | High | Low |
---|---|---|---|---|---|---|
Mar 28, 2023 | 0.9164 | 0.0185 | 2.06% | 0.8979 | 0.9201 | 0.8925 |
Mar 27, 2023 | 0.8951 | 0.0008 | 0.09% | 0.8943 | 0.9084 | 0.8580 |
Mar 24, 2023 | 0.8763 | 0.0682 | 8.44% | 0.8081 | 0.8924 | 0.8078 |
Mar 23, 2023 | 0.8150 | -0.0130 | -1.57% | 0.8280 | 0.8544 | 0.7941 |
Mar 22, 2023 | 0.7960 | -0.0021 | -0.26% | 0.7981 | 0.8149 | 0.7775 |
Mar 21, 2023 | 0.7603 | 0.0151 | 2.03% | 0.7452 | 0.7772 | 0.7283 |
Mar 20, 2023 | 0.7274 | -0.0656 | -8.27% | 0.7930 | 0.7931 | 0.7210 |
Mar 17, 2023 | 0.7449 | -0.0700 | -8.59% | 0.8149 | 0.8149 | 0.7283 |
Mar 16, 2023 | 0.7870 | -0.0179 | -2.22% | 0.8049 | 0.8091 | 0.7558 |
Mar 15, 2023 | 0.7945 | -0.0751 | -8.64% | 0.8696 | 0.8781 | 0.7677 |
Mar 14, 2023 | 0.8400 | -0.1078 | -11.37% | 0.9478 | 0.9541 | 0.8400 |
Mar 13, 2023 | 0.8952 | 0.0272 | 3.13% | 0.8680 | 0.9172 | 0.8505 |
Mar 10, 2023 | 0.8868 | -0.1109 | -11.12% | 0.9977 | 1.0077 | 0.8779 |
Mar 9, 2023 | 0.9977 | -0.0299 | -2.91% | 1.0276 | 1.0376 | 0.9937 |
Mar 8, 2023 | 1.0276 | -0.0699 | -6.37% | 1.0975 | 1.0975 | 1.0077 |
Mar 7, 2023 | 1.0276 | -0.0699 | -6.37% | 1.0975 | 1.1075 | 1.0176 |
Mar 6, 2023 | 1.0875 | -0.0200 | -1.81% | 1.1075 | 1.1175 | 1.0875 |
Mar 3, 2023 | 1.1175 | -0.0299 | -2.61% | 1.1474 | 1.1574 | 1.0875 |
Mar 2, 2023 | 1.1274 | -0.0100 | -0.88% | 1.1374 | 1.1574 | 1.0576 |
Mar 1, 2023 | 1.1274 | -0.1197 | -9.60% | 1.2471 | 1.2671 | 1.1174 |
Genprex, Inc. Events
Čas (UTC) (UTC) | Država | Dogodek |
---|---|---|
No events scheduled |
- Letni
- Četrtletno
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Skupni prihodki | 0 | 0 | 0 | 0 | 0 |
Prihodki | 0 | 0 | 0 | 0 | 0 |
Celotni odhodki iz poslovanja | 19.6008 | 17.9616 | 10.6827 | 12.3635 | 3.31235 |
Celotna prodaja/splošni/upravni stroški Odhodki | 10.9705 | 10.6359 | 8.7026 | 11.3862 | 3.01917 |
Raziskave in razvoj | 8.60775 | 7.30292 | 1.96701 | 0.97143 | 0.28993 |
Depreciation / Amortization | 0.02253 | 0.02278 | 0.01307 | 0.00589 | 0.00324 |
Prihodki iz poslovanja | -19.6008 | -17.9616 | -10.6827 | -12.3635 | -3.31235 |
Čisti dobiček pred obdavčitvijo | -19.5956 | -17.9428 | -10.6548 | -12.3723 | -3.31416 |
Čisti dobiček po davkih | -19.5956 | -17.9428 | -10.6548 | -12.3723 | -3.31416 |
Čisti dobiček pred dodatnimi postavkami | -19.5956 | -17.9428 | -10.6548 | -12.3723 | -3.31416 |
Čisti dobiček | -19.5956 | -17.9428 | -10.6548 | -12.3723 | -3.31416 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -19.5956 | -17.9428 | -10.6548 | -12.3723 | -3.31416 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -19.5956 | -17.9428 | -10.6548 | -12.3723 | -3.31416 |
Prilagoditev za redčenje | |||||
Popravljen čisti dobiček | -19.5956 | -17.9428 | -10.6548 | -12.3723 | -3.31416 |
Popravljene ponderirane povprečne delnice | 47.0973 | 35.5229 | 16.027 | 13.771 | 13.035 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -0.41607 | -0.5051 | -0.6648 | -0.89843 | -0.25425 |
Dividends per Share - Common Stock Primary Issue | 0 | ||||
Popravljen normalizirani dobiček na enoto čistega dobička | -0.41607 | -0.5051 | -0.6648 | -0.89843 | -0.25425 |
Prihodki (odhodki) od obresti, neto Neoperativni | 0.00513 | 0.01881 | 0.02791 | -0.0088 | -0.00181 |
Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | |
---|---|---|---|---|---|
Skupni prihodki | 0 | 0 | 0 | 0 | 0 |
Prihodki | 0 | 0 | 0 | 0 | 0 |
Celotni odhodki iz poslovanja | 6.11065 | 5.17507 | 5.72336 | 5.68292 | 3.43893 |
Celotna prodaja/splošni/upravni stroški Odhodki | 2.51112 | 2.4315 | 3.8558 | 2.19563 | 2.00044 |
Raziskave in razvoj | 3.59331 | 2.73703 | 1.86084 | 3.48033 | 1.432 |
Depreciation / Amortization | 0.00622 | 0.00654 | 0.00673 | 0.00696 | 0.00649 |
Prihodki iz poslovanja | -6.11065 | -5.17507 | -5.72336 | -5.68292 | -3.43893 |
Prihodki (odhodki) od obresti, neto Neoperativni | 0.02788 | 0.00574 | 0.00088 | 0.00099 | 0.00106 |
Čisti dobiček pred obdavčitvijo | -6.08278 | -5.16933 | -5.72248 | -5.68193 | -3.43787 |
Čisti dobiček po davkih | -6.08278 | -5.16933 | -5.72248 | -5.68193 | -3.43787 |
Čisti dobiček pred dodatnimi postavkami | -6.08278 | -5.16933 | -5.72248 | -5.68193 | -3.43787 |
Čisti dobiček | -6.08278 | -5.16933 | -5.72248 | -5.68193 | -3.43787 |
Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -6.08278 | -5.16933 | -5.72248 | -5.68193 | -3.43787 |
Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -6.08278 | -5.16933 | -5.72248 | -5.68193 | -3.43787 |
Popravljen čisti dobiček | -6.08278 | -5.16933 | -5.72248 | -5.68193 | -3.43787 |
Popravljene ponderirane povprečne delnice | 47.9847 | 47.8934 | 47.8796 | 47.8353 | 47.6124 |
Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -0.12676 | -0.10793 | -0.11952 | -0.11878 | -0.07221 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Popravljen normalizirani dobiček na enoto čistega dobička | -0.12676 | -0.10793 | -0.11952 | -0.11878 | -0.07221 |
- Letni
- Četrtletno
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 39.1402 | 27.7044 | 2.97664 | 8.84707 | 0.19357 |
Denarna sredstva in kratkoročne naložbe | 38.6289 | 27.3197 | 2.00249 | 8.60092 | 0.16125 |
Cash | 38.6289 | 27.3197 | 2.00249 | 8.60092 | 0.16125 |
Prepaid Expenses | 0.51135 | 0.38455 | 0.17172 | 0.23685 | 0.02348 |
Total Assets | 42.8623 | 31.3672 | 3.53423 | 9.26896 | 1.25954 |
Property/Plant/Equipment, Total - Net | 0.04861 | 0.03944 | 0.04465 | 0.02435 | 0.0078 |
Intangibles, Net | 3.66476 | 3.61267 | 0.4912 | 0.37945 | 0.29857 |
Other Long Term Assets, Total | 0.00869 | 0.01074 | 0.02173 | 0.01809 | 0.75959 |
Total Current Liabilities | 1.5853 | 0.45072 | 0.51068 | 0.38782 | 0.83096 |
Accounts Payable | 0.9732 | 0.19297 | 0.43626 | 0.29507 | 0.62907 |
Notes Payable/Short Term Debt | 0 | 0 | 0.07443 | 0.09275 | 0.20189 |
Total Liabilities | 1.5853 | 0.45072 | 0.51068 | 0.38782 | 0.83096 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Total Equity | 41.277 | 30.9165 | 3.02355 | 8.88114 | 0.42857 |
Preferred Stock - Non Redeemable, Net | |||||
Common Stock | 0.04787 | 0.04312 | 0.01926 | 0.01524 | 0.01172 |
Additional Paid-In Capital | 119.247 | 89.2956 | 43.4837 | 38.6906 | 17.8692 |
Retained Earnings (Accumulated Deficit) | -78.0179 | -58.4222 | -40.4795 | -29.8247 | -17.4524 |
Total Liabilities & Shareholders’ Equity | 42.8623 | 31.3672 | 3.53423 | 9.26896 | 1.25954 |
Total Common Shares Outstanding | 47.8747 | 43.1177 | 19.2638 | 15.2392 | 13.035 |
Celotne terjatve, neto | 0 | 0.00013 | 0.00066 | 0.0093 | 0.00884 |
Accounts Receivable - Trade, Net | 0 | 0.00013 | 0.00066 | 0.0093 | 0.00884 |
Total Inventory | 0.80178 | ||||
Other Current Liabilities, Total | 0.6121 | 0.25776 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Kratkoročna sredstva skupaj | 35.7031 | 39.1402 | 45.6447 | 48.0615 | 50.3777 |
Denarna sredstva in kratkoročne naložbe | 34.5553 | 38.6289 | 42.0205 | 44.2435 | 47.0687 |
Cash | 34.5553 | 38.6289 | 42.0205 | 44.2435 | 47.0687 |
Celotne terjatve, neto | 0.03217 | 0 | 0.00013 | 0.00013 | 0.00013 |
Accounts Receivable - Trade, Net | 0.03217 | 0 | 0.00013 | 0.00013 | 0.00013 |
Total Inventory | 2.87505 | 3.06236 | 3.1079 | ||
Prepaid Expenses | 1.1156 | 0.51135 | 0.74903 | 0.7556 | 0.201 |
Total Assets | 39.4094 | 42.8623 | 46.3272 | 48.7314 | 51.0365 |
Property/Plant/Equipment, Total - Net | 0.04188 | 0.04861 | 0.04434 | 0.03949 | 0.0373 |
Intangibles, Net | 3.65444 | 3.66476 | 0.62736 | 0.61967 | 0.6107 |
Other Long Term Assets, Total | 0.01 | 0.00869 | 0.01074 | 0.01074 | 0.01074 |
Total Current Liabilities | 2.38482 | 1.5853 | 1.16189 | 1.04722 | 0.61363 |
Accounts Payable | 1.25298 | 0.9732 | 0.59194 | 0.36979 | 0.33897 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 1.13184 | 0.6121 | 0.56995 | 0.67743 | 0.27466 |
Total Liabilities | 2.38482 | 1.5853 | 1.16189 | 1.04722 | 0.61363 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
Total Equity | 37.0246 | 41.277 | 45.1653 | 47.6842 | 50.4229 |
Common Stock | 0.04788 | 0.04787 | 0.0478 | 0.04752 | 0.04732 |
Additional Paid-In Capital | 120.717 | 119.247 | 117.453 | 116.535 | 115.287 |
Retained Earnings (Accumulated Deficit) | -83.7403 | -78.0179 | -72.3359 | -68.8981 | -64.9119 |
Total Liabilities & Shareholders’ Equity | 39.4094 | 42.8623 | 46.3272 | 48.7314 | 51.0365 |
Total Common Shares Outstanding | 47.8797 | 47.8747 | 47.8036 | 47.5229 | 47.3148 |
Other Equity, Total | 0 |
- Letni
- Četrtletno
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Čisti prihodki/začetna postavka | -19.5956 | -17.9428 | -10.6548 | -12.3723 | -3.31416 |
Denarna sredstva iz poslovanja | -14.2849 | -13.9351 | -6.91872 | -6.84653 | -2.17159 |
Denarna sredstva iz poslovanja | 0.02253 | 0.02278 | 0.01307 | 0.00589 | 0.00324 |
Nedenarne postavke | 4.27821 | 4.24619 | 3.52998 | 5.43538 | 1.32389 |
Spremembe v obratnem kapitalu | 1.00995 | -0.26128 | 0.19299 | 0.08454 | -0.18457 |
Denarna sredstva pri naložbenju | -0.0838 | -2.33725 | -0.9469 | -0.10332 | -0.06342 |
Kapitalski izdatki | -0.07244 | -0.12799 | -0.14512 | -0.10332 | -0.06342 |
Denarna sredstva pri financiranju | 25.6779 | 41.5895 | 1.26719 | 15.3895 | 0.79397 |
Izdaja (odplačilo) delnic, neto | 25.6779 | 41.5895 | 1.26719 | 15.3895 | 0.79397 |
Neto sprememba denarnih sredstev | 11.3092 | 25.3172 | -6.59843 | 8.43967 | -1.44104 |
Celotne druge postavke denarnih tokov pri naložbenju | -0.01136 | -2.20926 | -0.80178 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -5.72248 | -19.5956 | -13.9137 | -10.4758 | -6.48971 |
Cash From Operating Activities | -4.08386 | -14.2849 | -11.0668 | -8.43209 | -5.46528 |
Cash From Operating Activities | 0.00673 | 0.02253 | 0.01558 | 0.00909 | 0.00624 |
Non-Cash Items | 1.47011 | 4.27821 | 2.48457 | 1.8092 | 0.67174 |
Cash Taxes Paid | 0 | 0 | |||
Cash Interest Paid | 0 | 0 | |||
Changes in Working Capital | 0.16179 | 1.00995 | 0.34669 | 0.22545 | 0.34645 |
Cash From Investing Activities | 0.01032 | -0.0838 | 0.08978 | -0.07851 | -0.11003 |
Capital Expenditures | -0.00184 | -0.07244 | -0.04622 | -0.02719 | -0.10077 |
Other Investing Cash Flow Items, Total | 0.01216 | -0.01136 | 0.136 | -0.05132 | -0.00926 |
Cash From Financing Activities | 0 | 25.6779 | 25.6779 | 25.4344 | 25.3243 |
Issuance (Retirement) of Stock, Net | 0 | 25.6779 | 25.6779 | 25.4344 | 25.3243 |
Net Change in Cash | -4.07354 | 11.3092 | 14.7008 | 16.9238 | 19.749 |
Ime vlagatelja | Vrsta vlagatelja | Odstotek neporavnanih obveznosti | Delnice v lasti | Sprememba delnic | Datum imetništva | Ocena prometa |
---|---|---|---|---|---|---|
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 3.5144 | 1826600 | 1043 | 2022-12-31 | LOW |
Varner (John Rodney) | Individual Investor | 2.2348 | 1161535 | 625000 | 2023-02-18 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.069 | 555623 | 2408 | 2022-12-31 | LOW |
Confer (Ryan M.) | Individual Investor | 0.8379 | 435499 | 245000 | 2023-02-18 | MED |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.8314 | 432137 | -8520 | 2022-12-31 | LOW |
Berger (Mark Stanley) | Individual Investor | 0.4714 | 245000 | 245000 | 2023-02-18 | |
Vaczy (Catherine M) | Individual Investor | 0.4714 | 245000 | 245000 | 2023-02-18 | |
Kumar (Hermant) | Individual Investor | 0.3848 | 200000 | 200000 | 2023-02-18 | |
UBS Financial Services, Inc. | Investment Advisor | 0.3089 | 160546 | -119788 | 2022-12-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.2496 | 129739 | 0 | 2022-12-31 | LOW |
Cypress Capital, LLC | Investment Advisor | 0.1924 | 100000 | 0 | 2022-12-31 | MED |
Verus Capital Partners, LLC | Investment Advisor | 0.1703 | 88500 | -2000 | 2022-12-31 | MED |
Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.1663 | 86430 | 11029 | 2022-12-31 | LOW |
Group One Trading, L.P. | Research Firm | 0.1161 | 60354 | -79668 | 2022-12-31 | HIGH |
Silvercrest Asset Management Group LLC | Investment Advisor/Hedge Fund | 0.1077 | 56000 | 0 | 2022-12-31 | LOW |
Renaissance Technologies LLC | Hedge Fund | 0.1056 | 54900 | -18656 | 2022-12-31 | HIGH |
IHT Wealth Management, LLC | Investment Advisor | 0.1008 | 52375 | 0 | 2022-12-31 | LOW |
Staley Capital Advisers, Inc. | Hedge Fund | 0.0962 | 50000 | 0 | 2022-12-31 | LOW |
Citadel Advisors LLC | Hedge Fund | 0.0687 | 35688 | 21508 | 2022-12-31 | HIGH |
StoneX Group Inc. | Research Firm | 0.0676 | 35150 | 0 | 2022-12-31 | HIGH |
Zakaj izbrati Capital.com? Številke govorijo same zase.
Capital.com Group500K+
Borzni posredniki
92K+
Aktivne stranke mesečno
$53M+
Mesečni obseg naložb
$30M+
Dvigi vsak mesec
Kalkulator trgovanja
Izračunajte svoj hipotetični P&L, če bi trgovino s CFD odprli na določen datum (izberite datum) in jo zaprli na drug datum (izberite datum).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Genprex, Inc. Company profile
O družbi Genprex, Inc.
Genprex, Inc. je podjetje v klinični fazi genskega zdravljenja, ki se osredotoča na razvoj zdravil za zdravljenje raka in sladkorne bolezni. Družba razvija svoj vodilni kandidat za zdravilo za zdravljenje raka, zdravilo za imunogeno terapijo REQORSA (imenovano tudi GPX-001), za zdravljenje nedrobnoceličnega pljučnega raka (NSCLC). Zdravilna učinkovina v zdravilu REQORSA je plazmid za izražanje gena TUSC2, ki je zaprt v holesterolnem nanodelcu DOTAP. TUSC2 je tumorski supresorski gen, ki uničuje tumorje (prek apoptoze) in ima imunomodulatorne učinke. Družba uporablja svoj sistem za dostavo nanodelcev ONCOPREX za dostavo plazmida, ki izraža gen TUSC2, v rakave celice. Njeno gensko zdravljenje sladkorne bolezni, imenovano tudi GPX-002, je zasnovano tako, da pretvori celice alfa v trebušni slinavki v funkcionalne celice beta, ki lahko proizvajajo inzulin, vendar so dovolj različne od celic beta, da se izognejo imunskemu sistemu telesa.
Industry: | Bio Therapeutic Drugs |
Suite 3.322
1601 Trinity Street, Bldg. B
78712
Izkaz poslovnega izida
- Annual
- Quarterly
Ljudje gledajo tudi
Še vedno iščete posrednika, ki mu lahko zaupate?
Pridružite se 500.000+ trgovcem po vsem svetu, ki so se odločili za trgovanje s Capital.com